Osseus Fusion Systems, a Texas-based medical device company, this week announced the Alpha Launch of Aries-TS, a 3D printed transforaminal lumbar interbody fusion device. The system is designed for intervertebral body fusion procedures.

Founded in 2012, Osseus offers a range of products all developed for minimally invasive procedures. The new Aries-TS is the company’s first 3D printed transforaminal lumbar interbody fusion device. The new device is the latest in the company’s Aries product line, which also comprises the Aries-L, a lateral lumbar interbody fusion device, the first of which was successfully implanted a year ago.

“In January, we celebrated the one-year anniversary of the first implantation of the Aries-L lateral lumbar interbody fusion device so we are very excited to follow it up with the launch of the Aries-TS,” said Robert Pace, CEO of Osseus. “As a company committed to helping those in need of relief from chronic lumbar pain, we are confident that the Aries family of lumbar interbodies is a positive step toward that goal.”

Osseus’ Aries products are made up a highly porous titanium structure which has been optimized for bone fusion and biological fixation. The devices are manufactured using the company’s PL3XUS proprietary 3D printing technology—a powder bed fusion process capable of producing 80% porous implants.

The Aries implants are printed out of titanium powder at a layer resolution of 30 microns. They are then sintered in sequential layers, before undergoing an extensive proprietary post-processing cycle.

According to Osseus, its Aries implants are distinguished by a proprietary mesh lattice structure that reduces the stiffness of the cage and optimized bone graft packability. The mesh structure has also been designed to promote bone cell fixation and proliferation. To meet the various anatomical dimensions of patients, the Aries-TS and Aries-L both come in a wide range of footprints, heights and lordotic angles.

The newly released Aries-TS is designed for skeletally mature patients with degenerative disc disease of the lumbar spine who are undergoing intervertebral body fusion procedures.